Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours by Kitzen, J.J.E.M, de Jonge, M.J.A, Lamers, C.H.J, Eskens, F.A.L.M, van der Biessen, D, van Doorn, L, ter Steeg, J, Brandely, M, Puozzo, Ch, Verweij, J

Get full text